Cardiovascular Disease Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Cardiovascular Disease stocks.

Cardiovascular Disease Stocks Recent News

Date Stock Title
Nov 23 JNJ Trump picks surgeon Marty Makary to head FDA, Rep. Dave Weldon to lead CDC
Nov 22 CDIO Cardio Diagnostics files to sell 1.23M shares of common stocks by selling shareholders
Nov 22 JNJ Layoffs in 2024: A List of Companies Cutting Jobs This Year
Nov 22 JNJ J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis
Nov 22 JNJ Medtronic acquires Fortimedix Surgical to boost surgical portfolio
Nov 22 FLGT All You Need to Know About Fulgent Genetics (FLGT) Rating Upgrade to Strong Buy
Nov 22 JNJ Sanofi Plans to Change Hospital Drug-Discount Program
Nov 22 JNJ Health Canada issues NOC to J&J’s CARVYKTI for multiple myeloma
Nov 22 XENE JPMorgan Selects These 2 Stocks as Must-Haves for 2025
Nov 22 JNJ Johnson & Johnson seeks FDA approval for its ulcerative colitis treatment
Nov 22 JNJ Dividend Roundup: General Mills, Halliburton, Johnson & Johnson, Coca-Cola, and others
Nov 22 JNJ Johnson & Johnson seeks U.S. FDA approval for subcutaneous induction regimen of TREMFYA® (guselkumab) in ulcerative colitis, a first for an IL-23 inhibitor
Nov 22 JNJ Johnson & Johnson (NYSE:JNJ) Stock Goes Ex-Dividend In Just Three Days
Nov 22 NNOX Nano X Imaging Ltd (NNOX) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges ...
Nov 22 NNOX Q3 2024 Nano-X Imaging Ltd Earnings Call
Nov 21 JNJ Health Canada Authorizes CARVYKTI® (ciltacabtagene autoleucel) for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received One to Three Prior Lines of Therapy
Nov 21 NNOX Nano-X Imaging (NNOX) Q3 2024 Earnings Call Transcript
Nov 21 NNOX Nano-X Imaging Ltd. (NNOX) Q3 2024 Earnings Call Transcript
Nov 21 NNOX Nano-X Imaging Non-GAAP EPS of -$0.15 in-line, revenue of $3.03M misses by $0.5M
Nov 21 NNOX Nanox Announces Third Quarter of 2024 Financial Results and Provides Business Update
Cardiovascular Disease

Cardiovascular disease (CVD) is a class of diseases that involve the heart or blood vessels. Cardiovascular disease includes coronary artery diseases (CAD) such as angina and myocardial infarction (commonly known as a heart attack). Other CVDs include stroke, heart failure, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, heart arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, thromboembolic disease, and venous thrombosis.The underlying mechanisms vary depending on the disease. Coronary artery disease, stroke, and peripheral artery disease involve atherosclerosis. This may be caused by high blood pressure, smoking, diabetes, lack of exercise, obesity, high blood cholesterol, poor diet, and excessive alcohol consumption, among others. High blood pressure results in 13% of CVD deaths, while tobacco results in 9%, diabetes 6%, lack of exercise 6% and obesity 5%. Rheumatic heart disease may follow untreated strep throat.It is estimated that 90% of CVD is preventable. Prevention of atherosclerosis involves improving risk factors through: healthy eating, exercise, avoidance of tobacco smoke and limiting alcohol intake. Treating risk factors, such as high blood pressure, blood lipids and diabetes is also beneficial. Treating people who have strep throat with antibiotics can decrease the risk of rheumatic heart disease. The use of aspirin in people, who are otherwise healthy, is of unclear benefit.Cardiovascular diseases are the leading cause of death globally. This is true in all areas of the world except Africa. Together they resulted in 17.9 million deaths (32.1%) in 2015, up from 12.3 million (25.8%) in 1990. Deaths, at a given age, from CVD are more common and have been increasing in much of the developing world, while rates have declined in most of the developed world since the 1970s. Coronary artery disease and stroke account for 80% of CVD deaths in males and 75% of CVD deaths in females. Most cardiovascular disease affects older adults. In the United States 11% of people between 20 and 40 have CVD, while 37% between 40 and 60, 71% of people between 60 and 80, and 85% of people over 80 have CVD. The average age of death from coronary artery disease in the developed world is around 80 while it is around 68 in the developing world. Disease onset is typically seven to ten years earlier in men as compared to women.

Browse All Tags